Showing results (3021-3030 of 5,145) with videos related to

Sort By:
Pageof 515
Vox Sanguinis|February 13, 2014
Implementation and public acceptability: lessons from food irradiation and how they might apply to pathogen reduction in blood productsN M Heddle, S J Lane, N Sholapur, et al.
Vox Sanguinis|March 9, 2017
Safety and collection efficiency with a lower transfusion threshold for extracorporeal photopheresis in adult patients with graft-versus-host diseaseC Liu, E Schindler, M LeRoy, et al.
Vox Sanguinis|February 22, 2017
Three-year follow-up of implementation of evidence-based transfusion practice in a tertiary hospitalA Norgaard, J Stensballe, T H de Lichtenberg, et al.
Vox Sanguinis|February 22, 2017
Diverse and novel RHD variants in Australian blood donors with a weak D phenotype: implication for transfusion managementE C McGowan, G H Lopez, C M Knauth, et al.
Vox Sanguinis|February 22, 2017
Red blood cell concentrates treated with the amustaline (S-303) pathogen reduction system and stored for 35 days retain post-transfusion viability: results of a two-centre studyJ A Cancelas, J L Gottschall, N Rugg, et al.
Vox Sanguinis|January 26, 2017
Immature platelets do not reliably predict platelet recovery in patients with intensive chemotherapy or stem cell transplantationL Meintker, J D Fritsch, J Ringwald, et al.
Vox Sanguinis|January 5, 2017
Association of HLA-DRB1 and HLA-DQB1 with red-blood-cell alloimmunization in the Czech populationA Maluskova, F Mrazek, M Pauliskova, et al.
Vox Sanguinis|February 16, 2017
Patient outcomes and amotosalen/UVA-treated platelet utilization in massively transfused patientsW Nussbaumer, M Amato, H Schennach, et al.
Vox Sanguinis|January 19, 2017
Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromesY Lin, A Saskin, R A Wells, et al.
Vox Sanguinis|February 9, 2017
Transfusion medicine education for non-transfusion medicine physicians: a structured reviewY Lin, R L Haspel
Pageof 515